Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

BACKGROUND: In stable coronary artery disease, medications are used for 2 purposes: cardiovascular risk reduction and symptom improvement. In clinical trials and clinical practice, medication use is often not optimal. The ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Foley, Michael, Rajkumar, Christopher A., Shun‐Shin, Matthew, Ganesananthan, Sashiananthan, Seligman, Henry, Howard, James, Nowbar, Alexandra N., Keeble, Thomas R., Davies, John R., Tang, Kare H., Gerber, Robert, O’Kane, Peter, Sharp, Andrew S. P., Petraco, Ricardo, Malik, Iqbal S., Nijjer, Sukhjinder, Sen, Sayan, Francis, Darrel P., Al‐Lamee, Rasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955412/
https://www.ncbi.nlm.nih.gov/pubmed/33496201
http://dx.doi.org/10.1161/JAHA.120.017381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955412/
https://www.ncbi.nlm.nih.gov/pubmed/33496201
http://dx.doi.org/10.1161/JAHA.120.017381

Ejemplares similares